Ultivue
Ultivue and Evident Collaborate to Advance Multiplex Slide Imaging and Spatial Analysis in Translational Research
EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies. WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)—Evident Corporatio...
Ultivue and ZEISS to Co-Market Complete Solution for Spatial Phenomics
Carl Zeiss Microscopy, LLC, has announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue’s multiplex biomarker assays for tissue phenotyping with the ZEISS Axioscan whole...
Ultivue and ngTMA® Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research
CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational R...
Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige for AI-Powered Biomarker Imaging Solutions for Precision Medicine
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate...